Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$40.97 - $43.33 $33,513 - $35,443
818 Added 29.64%
3,578 $151,000
Q4 2023

Feb 09, 2024

BUY
$32.77 - $42.31 $16,024 - $20,689
489 Added 21.53%
2,760 $115,000
Q3 2023

Nov 13, 2023

SELL
$35.46 - $40.13 $27,836 - $31,502
-785 Reduced 25.69%
2,271 $85,000
Q2 2023

Aug 15, 2023

BUY
$24.24 - $40.97 $74,077 - $125,204
3,056 New
3,056 $115,000
Q3 2022

Nov 14, 2022

SELL
$28.74 - $39.9 $51,933 - $72,099
-1,807 Reduced 93.87%
118 $4,000
Q2 2022

Aug 12, 2022

SELL
$35.0 - $43.59 $13,545 - $16,869
-387 Reduced 16.74%
1,925 $70,000
Q1 2022

May 16, 2022

SELL
$43.12 - $50.3 $68,560 - $79,977
-1,590 Reduced 40.75%
2,312 $100,000
Q4 2021

Feb 14, 2022

SELL
$47.6 - $65.0 $53,169 - $72,605
-1,117 Reduced 22.26%
3,902 $195,000
Q3 2021

Nov 15, 2021

BUY
$62.34 - $73.38 $32,541 - $38,304
522 Added 11.61%
5,019 $319,000
Q2 2021

Aug 16, 2021

SELL
$70.26 - $76.64 $60,283 - $65,757
-858 Reduced 16.02%
4,497 $324,000
Q1 2021

May 13, 2021

BUY
$70.48 - $79.95 $19,170 - $21,746
272 Added 5.35%
5,355 $394,000
Q4 2020

Feb 09, 2021

SELL
$54.4 - $73.42 $15,395 - $20,777
-283 Reduced 5.27%
5,083 $373,000
Q3 2020

Nov 05, 2020

BUY
$54.41 - $68.2 $216,497 - $271,367
3,979 Added 286.88%
5,366 $294,000
Q2 2020

Aug 13, 2020

SELL
$61.66 - $70.16 $12,516 - $14,242
-203 Reduced 12.77%
1,387 $93,000
Q1 2020

May 14, 2020

BUY
$59.35 - $88.73 $94,366 - $141,080
1,590 New
1,590 $98,000

Others Institutions Holding TARO

About TARO PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TARO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 37,584,600
  • Description
  • Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...
More about TARO
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.